Search

Search Results
Results 17841 - 17850 of 19146 for breast cancer
  • Three essential biomarkers for measuring immune activation
    White Paper - 20 Apr 2026
    Accurate measurement of HMGB-1, neopterin and sIL-2R supports reliable assessment of immune activation across clinical and research applications.
  • Karvezide
    Drug - 20 Apr 2026
    Consumer Medicine Information (CMI) about Karvezide intended for persons living in Australia.
  • Avapro HCT
    Drug - 20 Apr 2026
    Consumer Medicine Information (CMI) about Avapro HCT intended for persons living in Australia.
  • Rybrevant
    Drug - 17 Apr 2026
    Consumer Medicine Information (CMI) about Rybrevant intended for persons living in Australia.
  • High-frequency ultrasound system for preclinical imaging
    Equipment - 13 Apr 2026
    High-frequency ultrasound platform for preclinical imaging, supporting real-time visualization of small animal anatomy and physiological function.
  • Imbruvica
    Drug - 13 Apr 2026
    Consumer Medicine Information (CMI) about Imbruvica intended for persons living in Australia.
  • Somac
    Drug - 26 Mar 2026
    Consumer Medicine Information (CMI) about Somac intended for persons living in Australia.
  • Somac Injection
    Drug - 26 Mar 2026
    Consumer Medicine Information (CMI) about Somac Injection intended for persons living in Australia.
  • Proquad
    Drug - 23 Mar 2026
    Consumer Medicine Information (CMI) about Proquad intended for persons living in Australia.
  • Selective PARP1 inhibitor discovery driven by translational modeling
    Health - 19 Mar 2026
    Translational research strategies enable identification of selective PARP1 inhibitors.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback